BGI Genomics Co., Ltd. (SHE:300676)
China · Delayed Price · Currency is CNY 44.47
-1.00 (-2.20%)
Oct 12, 2026, 2:45 PM CST
BGI Genomics Revenue
BGI Genomics had revenue of 979.86M CNY in the quarter ending June 30, 2026, with 2.06% growth. This brings the company's revenue in the last twelve months to 3.86B, up 6.46% year-over-year. In the year 2025, BGI Genomics had annual revenue of 3.71B, down -4.18%. That makes BGI Genomics the 10,415th largest company in the world by revenue and 1,699th in China.
Revenue (ttm)
3.86B
Revenue Growth
+6.46%
P/S Ratio
4.52
Revenue / Employee
1.08M
Employees
3,580
Market Cap
17.07B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.71B | -161.54M | -4.18% |
| Dec 31, 2024 | 3.87B | -482.72M | -11.10% |
| Dec 31, 2023 | 4.35B | -2.70B | -38.33% |
| Jan 1, 2023 | 7.05B | 287.01M | 4.24% |
| Jan 1, 2022 | 6.77B | -1.63B | -19.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.